Recruiting

Genetics in the Progression of Nephropathies

This study evaluates the role of genetic in the development and progression of different nephropaties with particular attention to: * AKI * CKD * Hypertension * ADPKD * CKD-MBD * Patients with decompensated heart failure undergoing either medical or surgery therapy * Patients with hematologic cancer exposed to chemotherapeutic agents or undergoing allogeneic bone marrow transplantation * glomerular diseases

ClinicalTrials.gov IDNCT06416761

PhaseNot Applicable

Enrollment10000

SponsorOspedale San Raffaele

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

AKI, CKD, Ckd-Mbd, CKD (Chronic Kidney Disease) Stage 5D, ADPKD, Hypertension, Hematologic Malignancy, Bone Marrow Transplant Complications

About this study

Interventions

Genetic: genetic polymorphisms

Primary outcomes

difference in glomerular filtration rate according to genetic profile (from days to 35 years)

Eligibility information

Inclusion Criteria: . presence of specific renal disease Exclusion Criteria: * to be evaluated in the different sub-protocols

Study locations

IRCCS Ospedale San Raffaele, Milan, 20132 Italy

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.